Bioactivity Screening Group

Organisational unit: Research Group

    Research areas

  • 317 Pharmacy - drug discovery, screening, antimicrobials, bacteria

Latest research outputs

  1. An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors

    Research output: Contribution to journalArticleScientificpeer-review

  2. DPD-inspired discovery of novel LsrK kinase inhibitors: an opportunity to fight antimicrobial resistance

    Research output: Contribution to journalArticleScientificpeer-review

ID: 2621871